DAGLA
Diacylglycerol lipase-alpha
Also known as: C11orf11, DAGLALPHA, DGLA_HUMAN, KIAA0659, NSDDR
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y4D2
- Gene
- DAGLA
- Ensembl
- ENSG00000134780
- Chromosome
- 11
- Canonical length
- 1042 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a diacylglycerol lipase. The encoded enzyme is involved in the biosynthesis of the endocannabinoid 2-arachidonoyl-glycerol.[provided by RefSeq, Nov 2010]
Canonical amino-acid sequenceUniProt
1042 residues, UniProt reviewed canonical sequence.
>Q9Y4D2|DAGLA
1 MPGIVVFRRR WSVGSDDLVL PAIFLFLLHT TWFVILSVVL FGLVYNPHEA CSLNLVDHGR
61 GYLGILLSCM IAEMAIIWLS MRGGILYTEP RDSMQYVLYV RLAILVIEFI YAIVGIVWLT
121 QYYTSCNDLT AKNVTLGMVV CNWVVILSVC ITVLCVFDPT GRTFVKLRAT KRRQRNLRTY
181 NLRHRLEEGQ ATSWSRRLKV FLCCTRTKDS QSDAYSEIAY LFAEFFRDLD IVPSDIIAGL
241 VLLRQRQRAK RNAVLDEANN DILAFLSGMP VTRNTKYLDL KNSQEMLRYK EVCYYMLFAL
301 AAYGWPMYLM RKPACGLCQL ARSCSCCLCP ARPRFAPGVT IEEDNCCGCN AIAIRRHFLD
361 ENMTAVDIVY TSCHDAVYET PFYVAVDHDK KKVVISIRGT LSPKDALTDL TGDAERLPVE
421 GHHGTWLGHK GMVLSAEYIK KKLEQEMVLS QAFGRDLGRG TKHYGLIVVG HSLGAGTAAI
481 LSFLLRPQYP TLKCFAYSPP GGLLSEDAME YSKEFVTAVV LGKDLVPRIG LSQLEGFRRQ
541 LLDVLQRSTK PKWRIIVGAT KCIPKSELPE EVEVTTLAST RLWTHPSDLT IALSASTPLY
601 PPGRIIHVVH NHPAEQCCCC EQEEPTYFAI WGDNKAFNEV IISPAMLHEH LPYVVMEGLN
661 KVLENYNKGK TALLSAAKVM VSPTEVDLTP ELIFQQQPLP TGPPMPTGLA LELPTADHRN
721 SSVRSKSQSE MSLEGFSEGR LLSPVVAAAA RQDPVELLLL STQERLAAEL QARRAPLATM
781 ESLSDTESLY SFDSRRSSGF RSIRGSPSLH AVLERDEGHL FYIDPAIPEE NPSLSSRTEL
841 LAADSLSKHS QDTQPLEAAL GSGGVTPERP PSAAANDEEE EVGGGGGGPA SRGELALHNG
901 RLGDSPSPQV LEFAEFIDSL FNLDSKSSSF QDLYCMVVPE SPTSDYAEGP KSPSQQEILL
961 RAQFEPNLVP KPPRLFAGSA DPSSGISLSP SFPLSSSGEL MDLTPTGLSS QECLAADKIR
1021 TSTPTGHGAS PAKQDELVIS ARLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DAGLA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 4
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 12 nTPM
- cerebellum: 7.8 nTPM
- hippocampal formation: 4.3 nTPM
- basal ganglia: 4.2 nTPM
- pancreas: 3.8 nTPM
- salivary gland: 3.7 nTPM
Single-cell type
- astrocytes: 20 nCPM
- peritubular myoid cells: 20 nCPM
- hepatic stellate cells: 19 nCPM
- retinal ganglion cells: 19 nCPM
- brain excitatory neurons: 17 nCPM
- retinal pigment epithelial cells: 17 nCPM
Immune cell
- intermediate monocyte: 0.3 nTPM
- non-classical monocyte: 0.3 nTPM
- classical monocyte: 0.2 nTPM
- myeloid DC: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 55 nTPM
- hippocampal formation: 48 nTPM
- thalamus: 39 nTPM
- white matter: 37 nTPM
- amygdala: 35 nTPM
- basal ganglia: 31 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DAGLA.
Disease | AllUniProt
Conditions DAGLA is implicated in, by any mechanism.
- Spinocerebellar ataxia 20 (SCA20) MIM:608687
- Neuroocular syndrome 2, paroxysmal type (NOC2) MIM:168885
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 177 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Benign paroxysmal tonic upgaze of childhood with ataxia
- See cases
- Inborn genetic diseases
ReferencesPubMed · IEDB
Publications for DAGLA from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
5 publications
- Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis.
2025 · Med · RCR 3.6 · 13 citations - Identification of DAGLA as an autoantibody target in cerebellar ataxia.
2024 · J Neurol Neurosurg Psychiatry · RCR 1 · 8 citations - Tremor and Ataxia in Paraneoplastic Anti-Diacylglycerol Lipase Alpha (DAGLA) Cerebellitis.
2025 · Cerebellum · 2 citations - DAGLA autoantibody experience at Mayo Clinic.
2025 · J Neurol · 1 citations - CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy.
2026 · J Neuroinflammation
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.17
- gnomAD pLI
- 1
- gnomAD missense Z
- 4.01
- DepMap mean gene effect
- -0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- arachidonate metabolic process
- cannabinoid biosynthetic process
- diacylglycerol catabolic process
- monoacylglycerol biosynthetic process
- neuroblast proliferation
- regulation of neuroinflammatory response
- retrograde trans-synaptic signaling by endocannabinoid
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DAGLA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DAGLA as an antibody target. Whether an autoantibody or antibody against DAGLA could matter depends on whether native DAGLA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DAGLA is annotated at the cell surface, where native DAGLA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label DAGLA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...